Home › NDC Lookup › RxCUI directory › RxCUI 2360899

Polyethylene glycol 400 10 MG/ML Ophthalmic Solution — RxCUI 2360899

RxNorm drug concept · Semantic clinical drug
RxCUI 2360899 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2360899
Official namePolyethylene glycol 400 10 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspolyethylene glycol 400 1 % Ophthalmic Solution
FDA products mapped5
Package NDCs mapped6
Reported Medicaid activity (SDUD)15 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Polyethylene glycol 400 10 MG/ML Ophthalmic Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Polyethylene glycol 400 10 MG/ML Ophthalmic Solution RxCUI 2360899

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Polyethylene glycol 400 8514
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Polyethylene glycol 400 Ophthalmic Solution 853237
    • Polyethylene glycol 400 Ophthalmic Product 1159893
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Polyethylene glycol 400 10 MG/ML 336921

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Polyethylene glycol 400 10 MG/ML SCDC · 336921
  • Polyethylene glycol 400 Ophthalmic Solution SCDF · 853237
  • Polyethylene glycol 400 Ophthalmic Product SCDG · 1159893

📦 FDA Products & Package NDCs

5 products · 6 package NDCs
6 package NDCs map to RxCUI 2360899 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
69968-0363-01 1 BOTTLE, DROPPER in 1 CARTON (69968-0363-1) / 15 mL in 1 B... Visine Dry Eye Relief Kenvue Brands LLC 2020-04-27
69968-0363-02 2 BOTTLE, DROPPER in 1 CARTON (69968-0363-2) / 15 mL in 1 B... Visine Dry Eye Relief Kenvue Brands LLC 2020-04-27
69968-0364-01 1 BOTTLE, DROPPER in 1 CARTON (69968-0364-1) / 15 mL in 1 B... Visine Dry Eye Relief Eye Drops Kenvue Brands LLC 2020-04-27
69968-0365-01 1 BOTTLE, DROPPER in 1 CARTON (69968-0365-1) / 15 mL in 1 B... Visine Dry Eye Relief Kenvue Brands LLC 2020-04-27
69968-0844-09 1 KIT in 1 PACKAGE (69968-0844-9) * 1 BOTTLE, DROPPER in 1... Visine Red Eye Total Comfort and Tears Dry Eye Relief Kenvue Brands LLC 2020-06-08
70677-1157-01 1 BOTTLE, DROPPER in 1 BOX (70677-1157-1) / 15 mL in 1 BOTT... Foster and Thrive Dry Eye Relief Strategic Sourcing Services LLC 2023-07-09
Observed labelers: Kenvue Brands LLC (5) · Strategic Sourcing Services LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.